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1. Introduction 
Heavy drinking during adolescence may have immediate as well as long-term detrimental 
consequences to bone health. The growing skeleton is especially prone to fracture and 
alcohol may exacerbate fracture risk. Furthermore, a disproportionate amount of peak bone 
mass is acquired during adolescence. Alcohol, by decreasing bone formation, may decrease 
peak bone mass, predisposing the skeleton to early onset osteoporosis. Although it is well 
known that heavy drinking can have detrimental skeletal effects in adults (Turner 2000), few 
studies have focused specifically on the skeletal consequences of underage drinking in 
human subjects, in part, due to the difficulty in performing alcohol intervention studies in 
underage drinkers. As a result, the significance of alcohol consumption during this interval 
of rapid bone accretion on skeletal health is largely unknown. Thus, relevant animal models 
are critical for identifying the effects and mechanisms of action of alcohol on bone 
metabolism during bone growth. This chapter will focus on the detrimental effects of 
alcohol on the maturing skeleton using the laboratory rat as a model. We will also present 
evidence that these effects are mediated, at least in part, by alcohol-induced alterations in 
energy homeostasis. 
2. Underage drinking 
2.1 Magnitude of problem 
Underage alcohol consumption is a major public health concern, especially in industrialized 
nations. The 2009 National Survey on Drug Use and Health reported that 10.4 million 
Americans between the ages of 12 and 17 had consumed alcohol during the month 
preceding the survey. Nearly 7 million of these teens reported engaging in binge drinking 
(5+ drinks on the same occasion) and 2.1 million classified themselves as heavy drinkers (5+ 
drinks per occasion on more than 5 days within the last month) (Department of Health and 
Human Services 2010). Rates of alcohol use, including binge and heavy drinking, have 
declined slightly since 2002; however alcohol consumption still occurs regularly in over 27% 
of American teenagers (Department of Health and Human Services 2010). High rates of 
alcohol consumption in youth were also reported in a 2008 survey of Australian secondary 
school students (White & Smith 2009). The European School Survey Project on Alcohol and 
Other Drugs, a survey of adolescent students in 35 European countries, reports even higher 
rates of alcohol use for European adolescents. The 2007 survey reported that within the 
month preceding the survey, 61% of students drank, 43% drank heavily, and 18% had been 
intoxicated (Hibell et al. 2009). However, none of these surveys provide insight regarding 
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the effects of underage drinking on bone growth or, if an injury were to occur, on bone 
repair following the injury. 
Globally, risky alcohol use among adolescents is on the rise (World Health Organization 
2011). Although most under-age drinkers do not become alcohol-dependent, they are at 
increased risk for a variety of injuries and disorders. Liver cirrhosis, epilepsy, various forms 
of cancer, cardiovascular disease, and diabetes are just a few of the disorders that have been 
causally linked to alcohol consumption (Department of Health and Human Services 2010). 
Furthermore, alcohol use increases the chances of both intentional and unintentional injuries 
to bone due to violence and accidents.  
2.2 Bone growth and maturation during adolescence 
The attainment of peak bone mass occurs sometime during the third decade of life (Recker 
et al. 1992; Lin et al. 2003) but adolescence is a key time period in determining peak bone 
mass. Bone accrued during the 2 years surrounding the pubertal growth spurt accounts for 
approximately 25% of peak bone mass (Kontulainen et al. 2007). Roughly 90% of bone mass 
is achieved by late adolescence (Henry et al. 2004; Whiting et al. 2004). Modifiable factors 
such as diet are important determinants of peak bone mass (Eisman 1999; Bergmann et al. 
2010; Ohlsson et al. 2011) and these effects may be compounded during the pubertal growth 
spurt. The introduction of factors inhibiting bone accrual during adolescence could lower 
peak bone mass and lead to decreased bone strength. A low peak bone mass, combined with 
age-related bone loss, has been shown to increase the likelihood of early onset osteoporosis, 
and the associated risk of fracture (Cooper et al. 2006; Xu et al. 2011). Reducing fracture risk 
in elderly osteoporotic populations is important, but 75% of the 6.8 million fractures 
occurring annually in the United States are not caused by osteoporosis. In fact, the group 
that accounts for the highest overall fracture rate is adolescent males (Goulding 2007). 
Heavy alcohol consumption may contribute to the high rate of fractures in this group.  
3. Effects of alcohol on bone metabolism in growing animals 
3.1 Animal models for investigating the effects and underlying mechanisms of action 
of alcohol on the maturing skeleton  
Due to size and cost considerations, rats and mice are generally the preferred animals for 
investigating the actions of alcohol on bone metabolism. The reader is directed to our review 
of the strengths and weaknesses of rodents as animal models for osteoporosis (Iwaniec & 
Turner 2008). In brief, rodents are similar to humans in that bone grows by a combination of 
endochondral ossification and periosteal bone formation. Similarly, following the pubertal 
growth spurt, endochondral ossification slows in magnitude and ultimately ceases (Martin 
et al. 2003), while periosteal bone formation continues at a slow rate throughout the 
remainder of life. Humans, rats and mice undergo age-related bone loss, but it is unclear 
whether the mechanisms for the bone loss are the same across species.  
Once formed, bone in humans is continuously remodeled. By repairing fatigue damage to 
bone, bone remodeling serves to maintain bone quality. Bone remodeling in rats is largely 
limited to endocortical and cancellous bone surfaces. Mice have very high rates of 
cancellous bone turnover but it is uncertain whether the close temporal and spatial 
integration of bone formation and resorption that characterizes bone remodeling in humans 
and rats occurs in mice. Haversion remodeling, the process by which cortical bone is 
remodeled in humans, is generally absent in small animals such as rats and mice. In spite of 
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differences from humans, rodents, especially rats, have proven extremely valuable as 
preclinical animal models for osteoporosis. Regarding alcohol, not only has the rat 
accurately modeled the skeletal effects of chronic alcohol abuse in adults, some of the 
changes in bone and mineral homeostasis originally reported in the rat were subsequently 
shown to occur in human alcoholics (Turner et al. 1987; Turner et al. 1988).  
There is no single pattern of alcohol consumption by underage drinkers. Drinking patterns 
range from occasional to regular, to binge. Based on dose-response and time-course studies 
in rats, the effects of alcohol on bone metabolism depend upon peak blood alcohol 
concentration and duration of exposure (Turner et al. 1998; Turner et al. 2001). As a 
consequence, no single animal model can replicate all of the actions of alcohol.  
To model chronic alcohol consumption, alcohol can be delivered to animals in drinking 
water, as a component of a liquid diet or as a component of total intragastric nutrition 
(Lieber et al. 1989; French 2001). Addition of alcohol to drinking water is the simplest 
method but has significant disadvantages. Because of aversion to alcohol, high 
concentrations decrease fluid intake which may result in dehydration (Lieber et al. 1989). In 
addition, it is difficult to equalize macro and micronutrient levels among treatment groups. 
In particular, the controls receive all of their energy and nutrients from a standard rodent 
chow diet. This contrasts with the alcohol fed animals who receive their energy from both 
alcohol and diet, and other nutrients from the chow diet only. Lieber and colleagues, 
recognizing the limitations of delivering alcohol in drinking water, developed a liquid diet 
in which alcohol replaced carbohydrates isocalorically (Lieber et al. 1989). We have found 
this diet to be very useful for investigating the effects of alcohol on bone metabolism.  
Total intragastric nutrition, while invasive and very labor intensive, is an alternative method 
which allows even better control of total nutrition. This method provides the investigator 
with complete control of the duration of exposure to alcohol. Thus, total intragastric 
nutrition is especially beneficial for delivering very high amounts of alcohol to induce a 
specific pathological response. However, because of exquisite sensitivity of the rodent 
skeleton to the metabolic effects of alcohol consumption, it is rarely necessary to employ 
alcohol levels that are high enough to require intragastric delivery. 
Binge drinking is typically modeled by oral gavage or by intraperitoneal injection. Alcohol 
can also be delivered by intermittent intragastric infusion. We have experience using the 
first two methods. Although intraperitoneal injection is a convenient method to deliver 
alcohol for short duration studies (Turner et al. 1998), we have found that intraperitoneal 
injection of alcohol over multiple days does not reproduce the response obtained following 
oral administration. Daily delivery of alcohol (~1.2 g/kg) by either gavage or intraperitoneal 
injection resulted in a peak blood alcohol level of ~0.1 %. This dose rate had no significant 
effects on body weight gain, uterine weight or bone parameters in animals where alcohol 
was delivered by gavage (unpublished data). In contrast, alcohol delivered by 
intraperitoneal injection injection resulted in decreased cortical bone mass and drastic 
reductions in bone formation and mRNA levels for bone matrix proteins (Turner et al. 1998). 
We conclude from this and similar experiments that multiple intraperitoneal injections have 
severe effects on the skeleton that do not model the normal physiological response to 
alcohol. 
Consistent with our data, Sampson et al. reported no detrimental effects on bone in growing 
rats using a model for binge drinking in which alcohol was administered by gavage on two 
consecutive days a week (Sampson et al. 1999). Based on the observation that longer 
exposure to relatively low blood levels of alcohol has greater effects on bone metabolism 
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than brief exposure to high blood levels of alcohol, we have focused on skeletal response of 
growing rats to chronic alcohol consumption. 
3.2 Effects of alcohol on the skeleton in growing rats 
Long duration studies in growing rats have shown that chronic alcohol consumption 
decreases peak bone mass. For example, administration of alcohol (38% caloric intake) to 
post-pubertal Long Evans hooded rats for 10 months resulted in a decrease in tibia length, 
an increase in the size of the marrow cavity and a decrease in cancellous bone mass (Turner 
et al. 1988). The latter is important because reduced cancellous bone mass plays a key role in 
the etiology of osteoporotic fractures. Studies designed to evaluate bone growth have shown 
that alcohol inhibits the rate of bone elongation as well as addition of bone onto periosteal 
and endocortical endocortical surfaces of rapidly growing male rats (Figure 1) (Turner et al. 
1987). These reductions in bone growth contribute to a decrease in bone mass. Similar 
changes were observed by Sampson and colleagues in growing female Sprague Dawley rats 
fed alcohol (Sampson et al. 1996; Hogan et al. 1997; Sampson et al. 1997; Sampson & Spears 
1999).  
 
 
Fig. 1. Representative microcomputed tomography images of tibiae from rats fed control or 
alcohol diets. In this study, 4-week-old male rats were fed a liquid diet containing alcohol 
for 4 months. Except for isocaloric replacement of ethanol with maltose dextran, the controls 
were fed the same diet ad libitum. Chronic alcohol consumption (35% caloric intake) during 
post pubertal growth reduced peak bone mass as illustrated above for the tibia. 
Bone formation is the product of osteoblast number and osteoblast activity. In growing rats, 
high levels of alcohol consumption were consistently found to decrease the extent of bone 
surface covered by active osteoblasts. The effect of alcohol on indices of osteoblast activity is 
less consistent, ranging from no effect to a moderate decrease. Alcohol results in a dose-
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associated decrease in osteoclast-lined bone surface (Turner et al. 2001). Thus, in addition to 
inhibiting bone formation, alcohol appears to inhibit bone resorption. Typical of low bone 
turnover forms of osteoporosis, bone loss in alcohol-fed rats is relatively slow (Hogan et al. 
2001; Turner et al. 2001), a finding consistent with the slow rate of bone loss observed in 
adult chronic alcohol abusers (Odvina et al. 1995; Pumarino et al. 1996).  
Chronic consumption of high levels of alcohol during growth reduces peak bone mass by 
inhibiting bone acquisition. However, there is conflicting evidence as to whether alcohol 
also impacts the extent of mineralization of bone matrix. Some, but not all, studies suggest 
that heavy drinking results in under-mineralization of bone matrix (Schnitzler & Solomon 
1984; Turner et al. 1987; Diamond et al. 1989; Bikle et al. 1993; Schnitzler et al. 1994). To 
investigate this issue more fully, we determined the effects of alcohol consumption on bone 
formed following osteoinduction by demineralized bone matrix. In this model, ectopic bone 
is induced to form at extraskeletal sites in an animal by subcutaneous implantation of 
demineralized bone matrix. Used clinically in orthopedic practice to augment bone 
formation during fracture repair, osteoinduction is an ideal method to investigate the effect 
of alcohol on mineralization because experiments can be designed in which bone is not 
present until introduction of alcohol into the diet. In our studies, described elsewhere in 
detail (Trevisiol et al. 2007), subcutaneously implanted demineralized allogeneic bone 
matrix cylinders were used to model osteoinduction. Demineralized allogeneic bone matrix 
cylinders, prepared from femurs and tibiae of rats fed a normal diet, were implanted into 
sexually mature male rats adapted to alcohol (ethanol contributed 35% of caloric intake) or 
control liquid diets. Food intake in the control rats was restricted to match food intake of 
alcohol-fed animals. The implants were recovered 6 weeks later and analyzed by histology, 
microcomputed tomography and chemical analysis. Histological evaluation revealed a 
robust osteoinductive response, resulting in mature bone formation, in implants in rats fed 
the control diet. Alcohol consumption affected architecture of the implants but not 
volumetric density or mineral composition. Specifically, alcohol consumption resulted in 
significant decreases in demineralized allogeneic bone matrix-induced bone volume, bone 
volume/mg original cylinder weight, connectivity density, trabecular number and 
thickness, ash weight and % ash weight. There were, however, no changes in mineral (ash) 
density nor in the relative amounts of calcium, magnesium, iron, selenium and zinc (g/mg 
ash), indicating that alcohol consumption reduced the amount of new bone formation but 
did not reduce mineral content of bone. 
Osteoinduction is a key component in fracture repair. The decrease in osteinduction 
observed in the rats described above and in subsequent studies (Iwaniec et al. 2008) suggest 
that alcohol may impair fracture healing. Chronic exposure to dietary alcohol inhibits 
healing in a variety of models involving injury to bone (Chakkalakal et al. 2005; Wahl et al. 
2005). However, it is not clear whether alcohol consumption has a clinically relevant effect 
on fracture healing in either humans or animal models. Addressing this important question 
should be a priority of future animal and human research. 
4. Alcohol metabolism 
It is not known whether the detrimental skeletal effects of alcohol on bone metabolism are 
due to the parent compound or a metabolite. The metabolism of ethanol occurs 
predominantly in the liver where ethanol is metabolized to acetaldehyde, a highly toxic 
metabolite, which in turn is rapidly metabolized to acetate. In addition to being released into 
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circulation from the liver, it is conceivable that acetaldehyde is produced in skeletal tissue. 
Such a mechanism could lead to local levels of acetaldehyde that exceed circulating levels. 
However, based on the inability of cultured osteoblasts to reduce ethanol levels in culture 
media, it seems unlikely that osteoblasts produce acetaldehyde (Maran et al. 2001). This 
observation does not preclude the possibility that other cells within the local skeletal 
environment metabolize alcohol or that circulating levels of acetaldehyde are sufficient to 
have direct actions on bone cells. Further investigation is required to establish the 
contribution of acetaldehyde to the detrimental effects of alcohol on bone.  
5. Does consuming alcohol have irreversible toxic effects on bone cells? 
The question as to whether alcohol leads to irreversible toxic effects on the skeleton is 
important but has not been fully resolved. Alcohol consumption results in a dose-
dependent decrease in bone formation that is paralleled by reductions in osteoblast-lined 
bone surface and osteoblast precursor pool in bone marrow (Dyer et al. 1998; Rosa et al. 
2008). Reduced bone formation is preceded by lower mRNA levels for bone matrix 
proteins (Turner et al. 2001). These and similar data are often interpreted as evidence of 
toxicity. In support of toxicity, there is incomplete catch-up growth following cessation of 
alcohol feeding in growing rats (Sampson & Spears 1999). Similarly, bone mass does not 
return to normal when alcohol feeding is discontinued in skeletally mature rats (Sibonga 
et al. 2007). Taken together, these findings suggest that alcohol has irreversible toxic 
effects on the osteoblast. This conclusion appears to be supported by in vitro studies 
reporting that direct exposure to alcohol decreases proliferation of cultured osteoblasts 
and inhibits their synthesis of bone matrix proteins (Giuliani et al. 1999; Vignesh et al. 
2006). However, the concentrations of alcohol necessary to achieve the detrimental effects 
in cell culture described above are generally very high, suggesting that mature osteoblasts 
are quite resistant to direct toxic effects of alcohol (Maran et al. 2001). In this regard, no 
direct toxicity was detected in dose-response studies performed on cultured human 
osteoblasts. Specifically, concentrations of ethanol that would be incompatible with 
human life had no effect on osteoblast number, proliferation or expression of genes for 
bone matrix proteins.  
In contrast to the high concentrations of ethanol (50mM or greater) required to have direct 
inhibitory effects on osteoblasts in cell culture, much lower levels of alcohol reduce bone 
formation in vivo. This finding suggests that the inhibitory effects of alcohol on bone 
formation are primarily indirect (Turner et al. 2001). To further evaluate whether alcohol has 
irreversible indirect toxic effects on osteoblasts, we performed studies in which we 
administered parathyroid hormone to rats that had been fed alcohol (Turner et al. 2001). The 
bone anabolic effects of intermittent parathyroid hormone have been studied in humans and 
laboratory animals and currently, parathyroid hormone is the only bone anabolic therapy 
approved by the Federal Drug Administration for the treatment of postmenopausal 
osteoporosis. Parathyroid hormone is effective in increasing bone mass in most but not all 
subjects. Thus, lifestyle factors such as alcohol consumption, may inhibit the skeletal 
response to parathyroid hormone. However, studies to date in rats suggest that parathyroid 
hormone and alcohol have opposite but independent effects on bone formation. In other 
words, alcohol lowered the basal rate of bone formation compared to animals fed a normal 
diet and parathyroid hormone increased bone formation by the same magnitude in animals 
fed normal and alcohol diets (Turner et al. 2001; Sibonga et al. 2007; Iwaniec et al. 2008; 
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Howe et al. 2011). Additionally, administration of parathyroid hormone reversed bone loss 
in alcohol-fed rats (Sibonga et al. 2007). Taken together, these findings do not support an 
irreversible toxic effect of alcohol on bone cells. Indeed, they suggest that bone formation 
returns to normal following removal of alcohol from the diet, but a pharmacological 
intervention may be required to restore the bone that had been lost. 
6. Mechanisms of action of alcohol on the growing skeleton 
6.1 Alcohol is an endocrine disruptor 
Bone metabolism is under tight endocrine control and it is well established that excessive 
alcohol consumption disrupts numerous endocrine functions. For example, alcohol 
consumption has been reported to alter the levels and skeletal responses to estrogen, 
vitamin D and parathyroid hormone (Dumitrescu & Shields 2005; Ronis et al. 2007; Sibonga 
et al. 2007). Each of these hormones play a key role in bone metabolism. As previously 
reviewed (Turner 2000; Turner & Sibonga 2001), disturbances in signaling by these 
hormones may contribute to the skeletal response to alcohol in adults. Less investigated, 
however, are the effects of alcohol on pituitary- (e.g., growth hormone) and adipocyte-
derived (e.g, leptin) hormones. Disruption of signalling of hormones that function to 
integrate growth and energy metabolism by alcohol has not been intensively studied, but 
may be especially important to the effects of underage drinking on bone growth and 
maturation. As discussed below, alcohol alters local production and/or circulating levels of 
bone regulating hormones, proinflammatory cytokines (TNF-┙) and adipokines related to 
energy intake and expenditure. In addition, there is evidence that alcohol results in end-
organ resistance to two of the key mediators of energy homeostasis, growth hormone and 
leptin. 
6.2 Impact of alcohol on energy metabolism 
6.2.1 Energy metabolism  
Bone growth during adolescence is tightly coupled to energy availability (Devlin et al. 2010). 
Regulation of energy metabolism involves the integration of signals from the digestive 
system, pancreas, liver, adipose tissue, hypothalamus and pituitary. The messengers that 
signal energy status and induce physiological adaptations consist of hormones, adipokines, 
cytokines, growth factors and neuronal networks. Alcohol consumption influences food 
intake and energy balance by altering the production and target organ response to these 
signals (Leibowitz 2005; Pravdova & Fickova 2006). As a consequence, we hypothesize that 
alcohol disrupts the tight coupling between energy availability and bone growth, 
maturation and turnover.  
6.2.2 Effect of alcohol on energy intake 
Alcohol has profound, dose-dependent effects on energy intake. Low concentrations of 
alcohol in the diet (0.5% and 3% caloric intake) were shown to enhance food consumption in 
rats (Turner et al. 2001; Turner & Iwaniec 2010). In contrast, higher alcohol concentrations 
generally suppress energy intake. Heavy alcohol consumption reduces bone formation in 
growing rats compared to pair-fed controls. However, pair-feeding underestimates the 
detrimental skeletal effects of alcohol consumption because self-selected caloric restriction in 
alcohol-fed rats also has detrimental effects on bone homeostasis (Maddalozzo et al. 2009).  
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6.2.3 Effect of alcohol on energy expenditure 
Total energy expenditure reflects the sum of basal metabolic rate and energy consumed 
performing physical activity. The effect of alcohol consumption on total energy expenditure 
appears to be context dependent. In short-duration studies, pair-feeding control rats to animals 
fed a diet containing alcohol usually equalizes weight gain among treatment groups, but not 
necessarily body composition (see below). Also, in a 10-month-long study, slightly more 
energy was required to achieve the same weight gain in rats fed a diet containing ethanol (38% 
caloric intake) than the rats fed the control diet (Turner et al. 1988). In a 4-month-long study 
investigating the skeletal response to physical activity, treadmill-exercised rats fed a diet in 
which alcohol contributed 35% of caloric intake gained weight in parallel with exercised 
animals fed the control diet. Furthermore, exercise decreased weight gain compared to pair-
fed non-exercising controls. Thus alcohol did not influence the increased energy requirements 
associated with a higher rate of physical activity. Overall, these findings suggest that alcohol 
does not have a major influence on overall energy expenditure.  
There are, however, situations where alcohol consumption does influence energy 
metabolism. Specifically, changes in hormonal regulators of energy homeostasis may alter 
the relationship between alcohol consumption and energy expenditure. For example, 
estrogen acts physiologically to reduce energy intake and increases expenditure. In 
ovariectomized rats, estrogen deficiency results in increased weight gain which is due to a 
combination of hyperphagia and reduced energy expenditure. Similar to estrogen, alcohol 
increased energy expenditure in ovariectomized rats. As a consequence, pair-fed 
ovariectomized rats consuming a control diet gain more weight than animals fed the alcohol 
containing diet (Kidder & Turner 1998).  
6.2.4 Body composition  
Body composition was altered in sexually mature male rats fed alcohol (35% caloric intake) 
for 3 months. The alcohol-fed animals had less peripheral fat and a lower whole body bone 
mineral content compared to age-matched controls (Maddalozzo et al. 2009). In spite of an 
overall reduction in fat mass, bone marrow adiposity was increased in the rats fed alcohol 
(Maddalozzo et al. 2009). Similar to rodents, reduced peripheral fat and increased bone 
marrow adiposity is associated with chronic alcohol abuse in men (Liangpunsakul et al. 
2010). In contrast, in a recent study investigating the role of estrogen in the skeletal response 
to alcohol we noted that heavy (35% caloric intake) alcohol consumption in slowly growing 
ovariectomized rats reduced overall body weight gain but increased white adipose tissue 
mass. Thus, there may be gender differences in the effects of alcohol on energy homeostasis.  
The role of peripheral and bone marrow fat in regulation of bone metabolism appears 
complex and has generated a great deal of interest in recent years. As discussed below, 
alcohol-induced changes in peripheral and bone marrow fat depots may play an indirect but 
nevertheless important role in mediating the detrimental effects of alcohol consumption on 
the adolescent skeleton. 
7. Alcohol disrupts the actions of key hormones that regulate energy 
metabolism 
7.1 Leptin signaling is required for normal bone growth  
As mentioned above, skeletal growth is tightly coupled to energy balance via complex and 
incompletely understood mechanisms. Leptin, the protein product of the ob gene, is 
www.intechopen.com
 Detrimental Effects of Alcohol on Bone Growth 65 
produced by adipocytes and functions as a messenger in a feedback loop between adipose 
tissue and the hypothalamus. As such, leptin contributes to the regulation of energy intake 
and expenditure (Figure 2). Leptin also acts on other organs, including bone. Leptin-
deficient ob/ob mice are morbidly obese and develop multiple pathologies associated with 
metabolic syndrome. Additionally, ob/ob mice have notable skeletal abnormalities. Initially, 
the ob/ob mouse was described as having high bone mass, but subsequent studies revealed a 
complex skeletal phenotype; compared to wild type (WT) mice, ob/ob mice have a low total 
and cortical bone but increased vertebral cancellous bone (Ducy et al. 2000; Bartell et al. 
2011). The decrease in cortical bone in ob/ob mice is in part due to a decrease in bone length.  
 
 
Fig. 2. Regulation of energy metabolism by leptin. Adipose tissue-derived leptin acts on the 
hypothalamus to increase energy expenditure and decrease appetite. These metabolic 
changes contribute to a negative feedback loop antagonizing further fat accumulation. 
Chronic alcohol consumption disrupts energy homeostasis by causing hypophagia, 
increased energy expenditure, and hypoleptinemia. Peripheral (serum) leptin functions 
physiologically to couple systemic growth (including bone growth) to energy availability. 
We hypothesize that chronic alcohol consumption during adolescence, by decreasing serum 
leptin levels, reduces bone growth which in turn contributes to the reduced peak bone mass 
observed in growing rats fed a diet containing alcohol. 
To evaluate the effect of hypothalamic signaling as a mediator of the skeletal response to 
leptin, we performed a study in which growing ob/ob mice were injected in the 
hypothalamus with either adeno-associated virus-leptin (rAAV-lep) or a control vector 
coding for green fluorescent protein (rAAV-GFP). Treatment with rAAV-lep restored the 
ob/ob skeletal phenotype to WT by increasing femoral length and total bone volume, and 
decreasing femoral and vertebral cancellous bone volume. As a consequence, at 15 weeks 
post-rAAV-lep injection the ob/ob mice no longer differed from WT mice (Iwaniec et al. 
2007). In recent unpublished studies we have shown that daily subcutaneous administration 
of leptin increases the longitudinal rate of bone growth in ob/ob mice as well as bone 
formation on cortical and cancellous bone surfaces. Taken together, these results suggest 
that leptin functions as an essential factor for normal bone growth and turnover.  
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7.2 Reduced leptin signaling as a mechanism for the detrimental effects of alcohol on 
bone growth 
Alcohol alters serum leptin levels in humans and animals (Nicolas et al. 2001; Santolaria et 
al. 2003; Calissendorff et al. 2004; Otaka et al. 2007; Maddalozzo et al. 2009). Decreased 
leptin levels are often associated with chronic alcohol consumption in humans, even after 
accounting for alcohol-induced reductions in fat mass (Nicolas et al. 2001; Calissendorff et 
al. 2004; Otaka et al. 2007). However, the change in leptin levels depends upon the level and 
pattern of alcohol consumption. In our model of chronic adolescent drinking, there is a 
substantial decrease in serum leptin levels (Figure 3). Additionally, there are studies 
suggesting that alcohol impairs leptin signaling by inducing target organ resistance to the 
hormone (Gordeladze et al. 2002).  
 
 
Fig. 3. Evidence for decreased leptin levels in serum of alcohol-fed rats compared to ad 
labium-fed (Ad lib) controls. Four-week-old male rats were fed alcohol containing 
(35%caloric intake) or control diets for 3 months. Data are mean ± SE, *P<0.05.  
Leptin, in addition to having central actions mediated through the hypothalamus, has the 
potential to act directly on target organs, including bone (Burguera et al. 2001; Reseland et 
al. 2001; Gordeladze et al. 2002; Thomas 2004). The putative hypothalamic-mediated and 
direct pathways of leptin action on bone metabolism have been reviewed by Hamrick 
(Hamrick et al. 2004; Hamrick & Ferrari 2008). By transplanting bone marrow cells from 
leptin receptor-deficient db/db mice into WT mice, we have shown that the physiological 
actions of leptin on bone turnover are primarily due to peripheral leptin signaling 
(Unpublished data). 
Leptin deficiency results in skeletal abnormalities that, in many ways, are similar to effects 
of chronic alcohol abuse. Specifically, leptin deficiency and alcohol consumption in growing 
rodents each result in decreases in longitudinal bone growth, radial bone growth, and 
cancellous bone turnover (Turner 2000; Iwaniec et al. 2007). Also, leptin deficiency and 
alcohol consumption in growing rodents each result in elevated bone marrow adiposity 
(Steppan et al. 2000; Hamrick et al. 2004; Hamrick et al. 2005; Hamrick & Ferrari 2008). Thus, 
one mechanism by which alcohol consumption may decrease bone acquisition during 
adolescence is by reducing leptin levels. Further studies are required to determine whether 
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normalization of leptin levels in alcohol-fed growing rats corrects the detrimental effects of 
alcohol on bone growth, architecture and turnover. 
8. Osteoblasts and adipocytes  
As discussed, we have shown that alcohol consumption increases bone marrow adiposity 
and decreases both bone formation and peak bone mass in a rat model for chronic alcohol 
abuse (Maddalozzo et al. 2009). Adipocytes and osteoblasts are derived from bone marrow 
mesenchymal stromal cells (Vaananen 2005; Gimble et al. 2006) (Figure 4). An inverse 
association between bone mass and bone marrow adiposity is commonly observed (Pei & 
Tontonoz 2004; Morita et al. 2006) and, although yet to be firmly established, several lines of 
evidence suggest that there is a cause and effect relationship. A deficiency in PPAR, a key 
mediator of adipocyte differentiation, reduced fat and enhanced osteogenesis (Akune et al. 
2004), suggesting that suppression of adipogenesis leads to increased bone formation. Based 
primarily on cell culture studies, some investigators have concluded that increased 
adipocyte differentiation inevitably occurs at the expense of osteoblast differentiation. If 
correct, the increase in bone marrow fat in alcohol-fed rats may play a causative role in the 
decrease in bone formation. In support of this idea, alcohol increased PPAR expression, 
increased adipocyte differentiation and decreased osteoblast differentiation in an 
immortalized mesenchymal stem cell line (Wezeman & Gong 2004). It should be mentioned, 
however, that a close inverse association between bone marrow fat and bone formation is 
not always apparent (Menagh et al. 2010; Turner & Iwaniec 2011). This has led us to suggest 
that changes in osteoblast differentiation are not inevitably coupled to changes in adipocyte 
differentiation. Instead, we have proposed that some regulatory factors have opposite 
effects on osteoblast and adipocyte differentiation but others have actions that are limited to 
one or the other cell lineage.  
 
 
Fig. 4. Osteoblasts and adipocytes are derived from bone marrow stromal cells. They 
produce factors that act locally to influence bone growth and turnover. Whereas leptin and 
IGF-I enhance bone formation, adiponectin and TNF- inhibit osteoblast differentiation. 
There is an alternative, non-mutually exclusive mechanism by which peripheral and/or bone 
marrow fat can influence bone metabolism. More than 50 adipocyte-derived adipokines, 
growth factors, and proinflammatory cytokines have been identified. Several of these factors, 
including leptin, adiponectin, tumor necrosis factor-alpha (TNF- and insulin-like growth 
factor-I (IGF-I) are known to have direct effects on bone cells. Adipocytes produce IGF-I in 
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response to growth hormone and are reported to be an important source of systemic IGF-I 
(Vikman et al. 1991). Although bone marrow adipocytes produce a spectrum of factors with 
differing effects on bone formation, most investigators believe that the factors which inhibit 
bone formation generally predominate. This belief is based on the observation that increased 
marrow fat is typically associated with osteopenia. If this interpretation is correct, chronic 
consumption of alcohol would tend to perpetuate a continued cycle where increased bone 
marrow fat would lead to additional fat accumulation and additional bone loss.  
 
Genes Related to Lipid Synthesis and Storage Change 
Sortilin  +4.7 fold 
Very-long-chain Acyl-CoA dehydrogenase +4.5 fold 
Glycerol-3-phosphate acyltransferase +6.7 fold 
Lipoprotein lipase +7.9 fold 
Non specific lipid transfer protein +2.9 fold 
Fatty acid synthase +3.8 fold 
Lysophospholipase +5.6 fold 
sn-glycerol-3-phosphate acyltransferase +4.7 fold 
Non-specific lipid transfer protein +2.9 fold 
Phosphatidate phospohydrolase type 2 +4.9 fold 
Phospholipase C +3.6 fold 
Phosphocholine cytidyltransferase +5.3 fold 
Branched chain ┙-keto acid dehydrogenase E1 +14.4 fold 
Genes Related to Lipolysis and β-Oxidation
3-Oxoacyl-CoA thiolase -3.2 fold 
DcoH -5.3 fold 
Ryudocan (Syndecan-4) -4.8 fold 
D-┚-hydroxybutyrate dehydrogenase -3.2 fold 
Genes Related to Adipocyte Differentiation, Function and/or 
IGF-I Signaling
 
Glucocorticoid receptor +2.5 fold 
Glucocorticoid regulated kinase +7.0 fold 
11-┚-hydroxysteroid dehydrogenase, type 2 +4.2 fold 
Stat5b -2.6 fold 
Alpha-1┚ adrenergic receptor +3.6 fold 
GPAT +4.7 fold 
PI3K -3.0 fold 
IP3 +3.2 fold 
Natriuretic factor precursor +6.1 fold 
ApoE  -11.6 fold 
Basic fibroblast growth factor (FGF) +3.4 fold 
FGF-receptor activating protein +6.1 fold 
12-lipoygenase -8.2 fold 
┚-nerve growth factor +2.7 fold 
Galanin  -2.7 fold 
VGAT -3.0 fold 
GABA-A receptor delta -2.7 fold 
Table 1. Alcohol increases expression of genes associated with adipogenesis and lipid 
synthesis and storage. 
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In order to identify key metabolic pathways impacted by alcohol on bone marrow fat, we 
analyzed the effects of chronic alcohol consumption on global gene expression (Affymetrix 
and Research Genetics rat chips) in the distal femur metaphysis (bone and marrow). In these 
studies, RNA isolated from individual animals (n=3/group) was analyzed. Alcohol 
significantly increased expression of key genes associated with fat storage and decreased 
expression of genes associated with lypolysis (Table 1). In addition, alcohol significantly 
increased expression of genes associated with adipogenesis. Many of the latter genes are 
differentially regulated by TNF- and IGF-I. Importantly, we have verified that alcohol 
results in rapid increases and decreases in TNF- and IGF-I gene expression, respectively 
(Turner et al. 1998). These results are consistent with the hypothesis that alcohol alters 
energy metabolism in bone marrow in a manner that promotes adipocyte formation and 
deposition of fat in the bone marrow, potentially at the expense of osteoblast formation. The 
results do not, however, provide a specific mechanism for the changes. 
9. Growth hormone signaling is required for normal bone growth and 
remodeling  
Growth hormone is the most important regulator of postnatal growth and has actions that 
overlap with leptin. Growth hormone plays multiple important direct and indirect roles in 
coupling energy expenditure to growth, including the growth of bone. Growth hormone 
deficiency in humans and animals is associated with decreased bone growth and osteopenia 
(Nilsson et al. 1995; Kasukawa et al. 2004). Osteoblasts and chondrocytes have receptors for 
growth hormone and the hormone elicits rapid effects on these cells in culture (Ohlsson et 
al. 1998). As discussed below, there is evidence that alcohol disrupts growth hormone 
signaling. 
9.1 Alcohol results in skeletal resistance to growth hormone 
Hypophysectomy prevented body weight gain and this effect was reversed by growth 
hormone treatment in rats regardless of dietary alcohol. Compared to normal rats, 
hypophysectomized rats had less cancellous bone, and lower rates of longitudinal growth 
and bone formation but higher bone marrow adiposity (Figure 5). Short duration (8 d) 
treatment of hypophysectomized rats with growth hormone increased cancellous bone 
formation and longitudinal growth rates, and decreased bone marrow adiposity. Alcohol 
consumption, however, blunted the effects of growth hormone on bone elongation, 
cancellous bone formation and bone marrow adiposity. These findings suggest that alcohol 
induces skeletal resistance to growth hormone at the level of the growth hormone receptor.  
There is precedence for skeletal resistance to growth hormone in rats. Skeletal resistance to 
growth hormone was reported in rat models for disuse (Bikle et al. 1995; Kostenuik et al. 
1999; Sakata et al. 2003; Sakata et al. 2004) and senescence (Ren et al. 1999). In regard to the 
former, alcohol has been shown to accentuate the detrimental skeletal effects of disuse 
(Hefferan et al. 2003). Further studies, however, are required to determine whether the 
putative resistance to growth hormone is due to reduced receptor number or impaired post-
receptor signaling. 
Osteoblasts, chondrocytes, and adipocytes have receptors for growth hormone, as do their 
stromal cell precursors, and the hormone elicits rapid effects on these cells in culture 
(Ohlsson et al. 1998). Growth hormone increases stromal cell number and differentiation of 
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stromal cells to osteoblasts. However, growth hormone suppresses adipocyte 
differentiation. As discussed below, alcohol-induced reductions in growth hormone 
signaling could be responsible for the observed changes in the balance between adipocyte 
and osteoblast differentiation.  
 
 
Fig. 5. Effects of hypophysectomy (panels A and B, proximal tibia, 36X objective) and 
alcohol consumption (panels C and D, lumbar vertebra, 20X objective) on bone marrow 
adiposity in growing male rats. Severe growth hormone deficiency induced by 
hypophysectomy resulted in very rapid (within days) increase in bone marrow adiposity in 
growing rats. An increase in adiposity is also observed in adolescent rats following 6 weeks 
of consuming alcohol. As described in the text, the increase in bone marrow fat in rats fed a 
diet containing alcohol is associated with skeletal resistance to growth hormone. 
Hypophysectomized animals are deficient in several hormones known to influence bone 
metabolism; including growth hormone, leptin, sex steroids, and adrenal and thyroid 
hormones. Thus, the profound skeletal changes resulting from hypophysectomy need not be 
exclusively due to growth hormone deficiency. However, we have shown that growth 
hormone replacement is sufficient to increase bone formation and decrease bone marrow 
adiposity to pituitary-intact control values. In contrast, administration of thyroxine, cortisol 
or 17┚-estradiol to hypophysectomized rats was ineffective in normalizing either bone 
formation or bone marrow adiposity (Menagh et al. 2010). Also, short duration treatment 
with growth hormone did not restore white adipose tissue mass or serum leptin levels to 
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normal. These findings suggest that the profound changes in leptin levels following 
hypophysectomy are not essential for the actions of growth hormone on bone growth, 
turnover or adiposity. Thus, growth hormone appears to be sufficient to increase bone 
formation and reduce bone marrow adiposity in hypophysectomized rats. However, 
pharmacological replacement with growth hormone may obscure the role of leptin 
deficiency as a regulator of bone metabolism. Physiologically, low leptin levels are 
associated with impaired growth hormone signaling. Thus, it is likely that leptin and 
growth hormone have overlapping effects on bone growth and turnover. 
9.2 Alcohol impairs IGF-I signaling in bone  
IGF-I mediates most, if not all, of the actions of growth hormone on bone and multiple lines 
of evidence indicate that IGF-I is essential for normal bone growth and remodeling. The 
activity of IGFs depends upon specific receptors, whose numbers are regulated, on target 
cells (Brown-Borg 2003). IGF-I, in addition to stimulating osteoblast differentiation, acts as 
an autocrine growth and survival factor for osteoblasts and may be essential for these cells 
to maintain their fully differentiated phenotype. Studies in mice and humans have 
confirmed the important actions of IGF-I on bone metabolism. IGF-I knockout mice are 
severely osteopenic and have reduced bone formation, despite the ability to produce growth 
hormone (Stabnov et al. 2002). The liver is the principal source of circulating IGFs. However, 
IGF-I is produced locally by osteoblasts, adipocytes and cartilage cells. The relative 
importance of locally produced versus systemic IGF-I on bone metabolism is under 
investigation. 
Compelling data support a role for locally produced IGF-I in regulation of bone metabolism. 
Targeted over-expression of IGF-I in mouse osteoblasts resulted in increased bone formation 
(Zhao et al. 2000), and osteoblast-derived IGF-I is required for the bone anabolic response to 
parathyroid hormone (Bikle et al. 2002; Wang et al. 2007). We have shown that parathyroid 
hormone increases bone formation in hypophysectomized rats. This response is 
accompanied by an increase in skeletal IGF-I mRNA levels with no rise in circulating IGF-I, 
illustrating the important role of locally produced IGF-I. However, equally compelling data 
support a role for circulating IGF-I in the regulation of bone metabolism. IGFs circulate 
bound to binding proteins which either potentiate or antagonize IGF-I activity in specific 
tissues, and the circulating levels of these binding proteins are regulated by a variety of 
factors (Jones & Clemmons 1995) Liver IGF-I-deficient (Lid) mice and acid labile subunit (a 
key component in the IGF-I serum transport complex) knockout (Alsko) mice exhibited 
relatively normal growth and development, despite having 75% and 65% reductions in 
serum IGF-I levels, respectively. The double knockout mice (LA), however, exhibited 
growth inhibitions and osteopenia that were reversed by IGF-I treatment (Yakar et al. 2002). 
More recent findings using a variety of model systems support a regulatory role for 
systemic IGF-I on bone metabolism (Yakar et al. 2002; Mohan et al. 2003; Wang et al. 2004; 
Mohan & Baylink 2005). Taken together, the above findings suggest that locally produced as 
well as circulating IGF-I are both important to skeletal growth and remodeling and are 
likely to have overlapping but not identical actions.  
There is mounting evidence that the skeletal effects of growth hormone, via IGF-I signaling, 
are impaired by alcohol consumption. Chronic alcohol abuse results in decreased serum IGF 
levels, reduced mRNA levels for IGF-I in liver and altered hepatic synthesis of IGF binding 
proteins (Turner et al. 1998; Lang et al. 2000). Locally, alcohol decreases IGF-I gene 
expression in bone (Turner et al. 1998). Alcohol may also reduce IGF receptor number in 
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target cells (Lang et al. 2000). Thus, the numerous ways that alcohol could disrupt IGF-I 
signaling fall into two general non-mutually exclusive classes of action: 1) decreased IGF-I 
bioavailability and 2) target organ resistance to GH. Exposure to alcohol rapidly (within 8 
hours) decreases mRNA levels for IGF-I in bone tissue (Figure 6). This decline precedes 
decreases in mRNA expression for bone matrix proteins and subsequent bone matrix 
synthesis (Turner et al. 1998). Thus, decreased production of IGF-I may play a causative role 
in mediating the inhibitory effects of alcohol on bone formation. Osteoblasts generate IGF-I 
and the growth factor is deposited into bone matrix where it is retained until released by 
osteoclast-mediated bone resorption. IGF-I located in bone matrix is thought to be 
osteoblast-derived but its origin has not been rigorously investigated. IGF-I in bone matrix, 
irrespective of origin, helps couple bone formation to bone resorption during bone 
remodeling; IGF-I released from the matrix during bone resorption acts in concert with 
other matrix-derived growth factors (e.g., TGF-ß) to induce renewed bone formation 
(Centrella et al. 1991; Mohan & Baylink 1991). Additionally, IGF-I incorporated into bone 
matrix plays a role in mediating bone healing when released following a fracture (Okazaki 
et al. 2003).  
 
 
Fig. 6. mRNA levels of IGF-I in distal femur are reduced within 8 h of administration of 
alcohol (1 g/kg) and return to normal by 24 hours. Values are man ± SE, n=4-5/group.  
*p <0.05 compared to time 0. 
9.3 Parathyroid hormone may reverse alcohol-induced inhibition of bone formation by 
increasing IGF-I gene expression in skeletal tissues 
The molecular mechanisms that mediate the bone anabolic response to parathyroid 
hormone are incompletely understood but appear to require IGF-I signaling. As mentioned, 
animals with low circulating levels of IGF-I have deficient bone formation (Yakar et al. 
2005). Also, bone in IGF-I knockout mice is insensitive to parathyroid hormone, suggesting 
that IGF-I is essential for the bone anabolic effects of the hormone (Miyakoshi et al. 2001; 
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Bikle et al. 2002). Acute administration of alcohol decreases IGF-I mRNA levels in liver and 
bone (Lang et al. 1998). Alcohol also reduces the circulating level of IGF-I. Thus, alcohol 
abuse could decrease the skeletal response to parathyroid hormone by reducing systemic 
and/or locally produced IGF-I or, alternatively, by inducing a target organ resistance to 
IGF-I signaling (Wang et al. 2007). Parathyroid hormone increases mRNA levels for IGF-I in 
skeletal tissue in rats (Watson et al. 1995) and the hormone has been shown to be effective in 
increasing cancellous bone formation in severely growth hormone-deficient 
hypophysectomized rats (Schmidt et al. 1995). Since hypophysectomized rats have very low 
serum IGF-I levels, locally generated IGF-I may be sufficient for the bone anabolic effects of 
parathyroid hormone (Fielder et al. 1996). However, other studies suggest that systemic 
IGF-I is critically important for the bone anabolic response to the hormone (Yakar et al. 
2006). Thus, parathyroid hormone-induced IGF-I in bone cells may compensate for the 
reduced circulating levels of the growth factor in alcohol-fed rats. Regardless of the relative 
importance of locally generated versus systemically derived IGF-I, parathyroid hormone 
increases cancellous bone formation in alcohol-fed rats without the requirement for 
restoring normal serum IGF-I levels. Taken together, these findings suggest that alcohol 
consumption results in a defect in growth hormone signaling that leads to impaired 
production of IGF-I by bone cells. Parathyroid hormone reverses this defect by its ability to 
increase IGF-I expression in bone cells by a growth hormone-independent mechanism. 
These findings provide a mechanistic explanation for the observed ability of parathyroid 
hormone to maintain normal bone formation in alcohol-fed rats and to reverse bone loss in a 
rat model for chronic alcohol abuse, whether or not alcohol is removed from the diet (Turner 
et al. 2001; Sibonga et al. 2007; Iwaniec et al. 2008; Howe et al. 2011). 
10. Alcohol may disturb estrogen signaling 
Although the skeletal changes in alcohol-fed rats are similar to those observed in growth 
hormone-deficient and leptin-deficient mice and rats, disruption of growth hormone and 
leptin signaling may represent only two of numerous mechanisms by which alcohol 
negatively impacts the growing skeleton. Disruption of estrogen signaling is another 
potential mechanism. We have already discussed estrogen as an important regulator of 
energy metabolism. In addition, estrogen is an important regulator of bone growth where 
the hormone plays an essential role in the sexual dimorphism of the skeleton (Turner et al. 
1994).  
The possible mechanisms by which alcohol could influence the skeletal response to 
estrogen on bone have been reviewed (Turner & Sibonga 2001). More recent in vitro 
studies suggest that very high concentrations of alcohol increase estrogen receptor levels 
but disrupt normal estrogen receptor signaling in cultured osteosarcoma cells (Chen et al. 
2006; Chen et al. 2009). It is not clear, however, whether the much lower levels of alcohol 
exposure experienced by most adolescent drinkers would have this effect. Also, alcohol 
consumption results in similar skeletal abnormalities in male and female growing rats. In 
contrast, whereas estrogen receptor blockade by the potent estrogen receptor antagonist 
ICI 182,780 largely recapitulates the skeletal response to ovariectomy, the antagonist had 
no effect on bone growth and turnover in growing male rats (Sibonga et al. 1998; Turner et 
al. 2000). Therefore, alterations of estrogen receptor signaling may contribute to but are 
unlikely to be the major cause for the detrimental effects of alcohol consumption on the 
growing skeleton. 
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11. Summary 
The skeletal changes in growing rats consuming alcohol are similar to the skeletal changes 
observed in growth hormone-deficient rats; decreased bone elongation, decreased cortical 
and cancellous bone mass, decreased bone formation and resorption, and increased bone 
marrow adiposity. Studies performed in hypophysectomized rats suggest that growth  
 
 
Fig. 7. A simplified model for the coupling of bone growth and turnover to energy 
metabolism. Systemic and osteoblast-generated IGF-I are bone anabolic whereas leptin has 
direct and indirect hypothalamic effects on cancellous bone. We hypothesize that the 
detrimental effects of alcohol on bone metabolism are mediated through changes in key 
hormones involved in the tight coupling between energy homeostasis and bone growth. 
Alcohol-impaired IGF-I and leptin signaling results in depressed bone growth, depressed 
osteoblast differentiation and increased bone marrow adiposity. Finally, the alcohol-induced 
increase in bone marrow adiposity results in increased local levels of TNF-┙ and other 
inhibitory adipokines which further inhibits osteoblastogenesis. Other factors that may 
contribute to the detrimental effects of alcohol on bone metabolism include: impaired 
growth hormone (GH)-growth hormone receptor (GH-R) interactions, impaired IGF-I-IGF-I 
receptor (IGF-I-R) interactions, impaired growth hormone releasing hormone (GHRH) 
secretion from the hypothalamus and/or decreased deposition of IGF-I into bone matrix. 
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hormone is essential to maintain a mature osteoblast phenotype and suppress excessive 
adipogenesis. We have also shown that alcohol impairs the action of growth hormone to 
increase bone growth and turnover, and decrease bone marrow adiposity in 
hypophysectomized rats. These results are consistent with skeletal resistance to growth 
hormone as a contributing mechanism for the detrimental skeletal effects of chronic alcohol 
consumption. Other studies suggest that heavy drinking decreases energy intake and in 
some situations can increase energy expenditure. It is likely that reduced leptin signaling is, 
at least in part, responsible for changes in energy homeostasis. Reduced leptin levels may 
also contribute to the alcohol-induced inhibition of bone growth and turnover, and increase 
in bone marrow adiposity. Thus impairments in growth hormone and leptin signaling may 
act in consort to mediate the reduced peak bone mass in rats fed a diet containing alcohol. 
Although our work to date has focused on leptin and growth hormone, it does not preclude 
an important role for other factors, such as estrogen, that facilitate the coupling of bone 
growth to energy metabolism. As depicted in our working model (Figure 7), alcohol 
consumption may also decrease the deposition of growth factors into bone matrix prior to 
its mineralization. Thus, heavy underage drinking, in addition to an immediate increase in 
the likelihood of a fracture, may have serious long-term consequences to bone health. By 
decreasing peak bone mass, heavy alcohol consumption may increase the risk for premature 
osteoporosis and by decreasing the incorporation of skeletal growth factors into bone during 
formation, alcohol may increase the risk for impaired healing should a fracture occur. 
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